JP2004528809A5 - - Google Patents

Download PDF

Info

Publication number
JP2004528809A5
JP2004528809A5 JP2002532629A JP2002532629A JP2004528809A5 JP 2004528809 A5 JP2004528809 A5 JP 2004528809A5 JP 2002532629 A JP2002532629 A JP 2002532629A JP 2002532629 A JP2002532629 A JP 2002532629A JP 2004528809 A5 JP2004528809 A5 JP 2004528809A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
sequence seq
consensus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002532629A
Other languages
English (en)
Other versions
JP4465148B2 (ja
JP2004528809A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/031488 external-priority patent/WO2002029059A2/en
Publication of JP2004528809A publication Critical patent/JP2004528809A/ja
Publication of JP2004528809A5 publication Critical patent/JP2004528809A5/ja
Application granted granted Critical
Publication of JP4465148B2 publication Critical patent/JP4465148B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【０３９８】
配列表のための手がかり：
配列番号１ ゲノム配列ＡＣ０１３６０６由来のヒトＮｇＲ２ ｃＤＮＡ配列
配列番号２ ヒトＮｇＲ２アミノ酸配列
配列番号３ ＡＣ０２１７６８由来のマウスＮｇＲ３ ｃＤＮＡ配列
配列番号４ マウスＮｇＲ３アミノ酸配列
配列番号５ ヒトＮｇＲ１アミノ酸配列
配列番号６ ＮｇＲのコンセンサスアミノ酸配列
配列番号７ ｈＮｏｇｏＡ（Ｎｏｇｏ−６６）の番号１０５５〜１１２０アミノ酸残基
配列番号８ 成熟ヒトＮｇＲ２アミノ酸配列
配列番号９ 成熟マウスＮｇＲ３アミノ酸配列
配列番号１０ コンセンサスＮｇＲ ＬＬＲＮＴアミノ酸配列
配列番号１１ コンセンサスＮｇＲ ＬＲＲＣＴドメインアミノ酸配列
配列番号１２ コンセンサスＮｇＲ ＬＲＲドメインアミノ酸配列
配列番号１３ 部分ヒトＮｇＲ３ヌクレオチド配列
配列番号１４ 部分ヒトＮｇＲ３アミノ酸配列
配列番号１５ ヒトＮｇＲ２配列をコードするゲノム配列
配列番号１６ マウスＮｇＲ３をコードするゲノム配列（相補鎖）
配列番号１７ マウスＮｇＲ１アミノ酸配列
配列番号１８ ＮｇＲのＮＴＬＲＲＣＴドメインについてのコンセンサス配列
配列番号１９ コンセンサスＮｇＲ ＬＲＲＣＴドメインアミノ酸配列。
【配列表】
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
Figure 2004528809
JP2002532629A 2000-10-06 2001-10-06 Ｎｏｇｏレセプターホモログ Expired - Fee Related JP4465148B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23836100P 2000-10-06 2000-10-06
PCT/US2001/031488 WO2002029059A2 (en) 2000-10-06 2001-10-06 Nogo receptor homologs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009022063A Division JP2009100767A (ja) 2000-10-06 2009-02-02 Ｎｏｇｏレセプターホモログ

Publications (3)

Publication Number Publication Date
JP2004528809A JP2004528809A (ja) 2004-09-24
JP2004528809A5 true JP2004528809A5 (ja) 2005-03-03
JP4465148B2 JP4465148B2 (ja) 2010-05-19

Family

ID=22897532

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002532629A Expired - Fee Related JP4465148B2 (ja) 2000-10-06 2001-10-06 Ｎｏｇｏレセプターホモログ
JP2009022063A Withdrawn JP2009100767A (ja) 2000-10-06 2009-02-02 Ｎｏｇｏレセプターホモログ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009022063A Withdrawn JP2009100767A (ja) 2000-10-06 2009-02-02 Ｎｏｇｏレセプターホモログ

Country Status (12)

Country Link
US (5) US20030124704A1 (ja)
EP (1) EP1325130B1 (ja)
JP (2) JP4465148B2 (ja)
AT (1) ATE458815T1 (ja)
AU (2) AU1153902A (ja)
CA (1) CA2424834A1 (ja)
DE (1) DE60141409D1 (ja)
DK (1) DK1325130T3 (ja)
ES (1) ES2341608T3 (ja)
NZ (1) NZ525422A (ja)
PT (1) PT1325130E (ja)
WO (1) WO2002029059A2 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119165B2 (en) 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
DK1325130T3 (da) * 2000-10-06 2010-05-25 Univ Yale Nogo-Receptorhomologer
EP1423427A2 (en) * 2001-08-27 2004-06-02 Novartis AG Nogo receptor homologues and their use
JP2005519584A (ja) * 2001-10-22 2005-07-07 ノバルティス アクチエンゲゼルシャフト Ｎｏｇｏレセプターホモログおよびそれらの使用
US7309485B2 (en) * 2001-12-03 2007-12-18 Children's Medical Center Corporation Reducing myelin-mediated inhibition of axon regeneration
AU2003246254A1 (en) * 2002-07-05 2004-01-23 Shionogi And Co., Ltd. NOVEL Nogo RECEPTOR-LIKE POLYPEPTIDE AND DNA THEREOF
BR0313331A (pt) 2002-08-10 2007-07-24 Univ Yale antagonistas de receptor de nogo
PL378582A1 (pl) 2003-03-19 2006-05-02 Biogen Idec Ma Inc. Białko wiążące receptor Nogo
US7541335B2 (en) 2003-04-04 2009-06-02 University Of Rochester Nogo-receptors and methods of use
US20070065429A1 (en) * 2003-04-16 2007-03-22 Biogen Idec Ma Inc. Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques
US20080274112A1 (en) * 2003-08-07 2008-11-06 Lee Daniel H S Nogo Receptor Antagonists
US8912144B2 (en) * 2003-12-16 2014-12-16 Children's Medical Center Corporation Method for treating stroke via administration of NEP1-40 and inosine
US20080274077A1 (en) * 2003-12-16 2008-11-06 Children's Medical Center Corporation Method for Treating Neurological Disorders
JP2007519737A (ja) * 2004-01-30 2007-07-19 バイオジェン・アイデック・エムエイ・インコーポレイテッド Ｎｏｇｏレセプターアンタゴニストを使用するドーパミンニューロン変性に関する状態の処置
AU2005258335B2 (en) 2004-06-24 2011-03-17 Biogen Ma Inc. Treatment of conditions involving demyelination
WO2006047049A2 (en) * 2004-10-01 2006-05-04 Yale University Nogo-a polypeptide fragments, variant nogo receptor-1 polypeptides, and uses thereof
EP1904091A4 (en) * 2005-07-07 2009-12-23 Univ Yale COMPOSITIONS AND METHODS FOR SUPPRESSING THE INHIBITION OF AXON GROWTH
MX2008000253A (es) 2005-07-08 2008-04-02 Biogen Idec Inc Anticuerpos de sp35 y usos de los mismos.
CA2619406A1 (en) * 2005-08-25 2007-03-01 Biogen Idec Ma Inc. Nogo receptor polypeptides and polypeptide fragments and uses thereof
ES2550099T3 (es) 2006-01-27 2015-11-04 Biogen Ma Inc. Antagonistas del receptor Nogo
JP2009538282A (ja) * 2006-05-15 2009-11-05 バイオジェン・アイデック・エムエイ・インコーポレイテッド 乏突起膠細胞の生存を促進させるためのＮｏｇｏ受容体−１（ＮｇＲ１）アンタゴニストの使用
US20080025959A1 (en) * 2006-05-24 2008-01-31 Richard Daneman Permeability of blood-brain barrier
EP2503341A3 (en) * 2006-11-14 2012-10-03 Genentech, Inc. Modulators of Neuronal Regeneration
US20100047232A1 (en) * 2006-11-14 2010-02-25 Jasvinder Atwal Modulators of neuronal regeneration
WO2009009743A2 (en) * 2007-07-12 2009-01-15 Institute For Advance Study Sequence optimization for expression of a foreign gene
AU2008335245A1 (en) * 2007-12-11 2009-06-18 Genentech, Inc. Modulators of neuronal regeneration
WO2009114197A2 (en) 2008-03-13 2009-09-17 Yale University Reactivation of axon growth and recovery in chronic spinal cord injury
CL2009001155A1 (es) * 2008-05-13 2010-06-04 Genentech Inc Anticuerpo anti-pirb/lilrb aislado; polinucleotido que lo codifica; vector; celula huesped; metodo de obtencion; composicion farmaceutica que lo comprende; kit; y su uso para tratar enfermedades neurodegenerativas.
EP2315779A2 (en) 2008-07-09 2011-05-04 Biogen Idec MA Inc. Compositions comprising antibodies to lingo or fragments thereof
EP2392208B1 (en) * 2010-06-07 2016-05-04 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use
US9120111B2 (en) 2012-02-24 2015-09-01 Rain Bird Corporation Arc adjustable rotary sprinkler having full-circle operation and automatic matched precipitation
CN104470541A (zh) 2012-05-14 2015-03-25 比奥根艾迪克Ma公司 用于治疗涉及运动神经元的疾患的lingo-2拮抗剂
US9156043B2 (en) 2012-07-13 2015-10-13 Rain Bird Corporation Arc adjustable rotary sprinkler with automatic matched precipitation
JP2018504400A (ja) 2015-01-08 2018-02-15 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． Ｌｉｎｇｏ‐１拮抗薬及び脱髄障害の治療のための使用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250414A (en) 1988-11-04 1993-10-05 Erziehungsdirektion Of The Canton Zurich Diagnostic methods using neurite growth regulatory factors
WO1990005191A1 (en) 1988-11-04 1990-05-17 Erziehungsdirektion Of The Canton Zurich Neurite growth regulatory factors
CA1341050C (en) 1988-11-04 2000-07-11 Martin E. Schwab Neurite growth regulatory factors
JPH07509002A (ja) 1993-02-11 1995-10-05 エルツィーヒュングスディレクション　オブ　ザ　キャントン　チューリッヒ ニューロトロフィンとミエリン−関連の軸索成長阻害タンパク質に対する抗体との組み合わせが中枢神経系の再生を促進する
WO2000073452A2 (en) 1999-06-02 2000-12-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
WO2000053758A2 (en) 1999-03-08 2000-09-14 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US5858708A (en) 1996-08-12 1999-01-12 Bandman; Olga Polynucleotides encoding two novel human neuroendocrine-specific proteins
JP2003521216A (ja) * 1997-08-05 2003-07-15 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ９０個のヒト分泌タンパク質
NZ507435A (en) 1998-03-10 2003-12-19 Genentech Inc Novel polypeptides and nucleic acids with homology to cornichon
AU4682999A (en) * 1998-06-16 2000-01-05 Human Genome Sciences, Inc. 94 human secreted proteins
JP2002522016A (ja) 1998-07-22 2002-07-23 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 神経内分泌特異的タンパク質に類似したタンパク質、およびそれをコードするｃＤＮＡ
CZ304224B6 (cs) * 1998-11-06 2014-01-15 Schwab Monoklonální protilátka
JP3695642B2 (ja) 1998-12-01 2005-09-14 ジェネンテック・インコーポレーテッド 血管形成及び心臓血管新生の促進又は阻害
DE69940964D1 (de) 1998-12-22 2009-07-16 Genentech Inc Verfahren und Zusammensetzungen zur Hemmung des neoplastischen Zellenwachstums
EP1263948A2 (en) 1999-03-08 2002-12-11 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000058473A2 (en) 1999-03-31 2000-10-05 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; 'orfx'
AU3632600A (en) 1999-05-14 2000-12-05 Genentech Inc. Compositions and methods for the treatment of immune related diseases
EP1268506A4 (en) 1999-07-30 2004-07-28 Millennium Pharm Inc SECRET PROTEINS AND THEIR USE
AU2575901A (en) 1999-12-08 2001-06-18 Millennium Pharmaceuticals, Inc. Novel leucine rich repeat-containing molecules and uses therefor
CZ20022438A3 (cs) * 2000-01-12 2002-10-16 Yale University Nukleová kyselina kódující receptor Nogo, izolovaný polypeptid a farmaceutický přípravek pro stimulaci růstu axonů
US7119165B2 (en) * 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
CA2376873A1 (en) 2000-04-18 2001-10-25 Teijin Limited Oxygen concentrating apparatus
DK1325130T3 (da) * 2000-10-06 2010-05-25 Univ Yale Nogo-Receptorhomologer
EP1423427A2 (en) 2001-08-27 2004-06-02 Novartis AG Nogo receptor homologues and their use
JP2005519584A (ja) 2001-10-22 2005-07-07 ノバルティス アクチエンゲゼルシャフト Ｎｏｇｏレセプターホモログおよびそれらの使用
BR0313331A (pt) 2002-08-10 2007-07-24 Univ Yale antagonistas de receptor de nogo

Similar Documents

Publication Publication Date Title
JP2004528809A5 (ja)
JP2004511201A5 (ja)
JP2002503641A5 (ja)
JP2001524320A5 (ja)
JP2001514013A5 (ja)
IL163066A (en) Ligands for the zcytor17 receptor
JP2003533986A5 (ja)
BR0010361A (pt) Seq ências genÈmicas de neisseria e uso destas
MX339406B (es) Antigenos de neisseria meningitidis y composiciones que los contienen.
EP1246114A3 (en) Methods for genomic analysis
JP2003192699A5 (ja)
EP1035870A4 (en) COMPOSITIONS AND METHODS FOR TREATING HEPATITIS C VIRUS DISEASES
CA2143678A1 (en) Compositions and methods for treatment of hepatitis c virus-associated diseases
JP2009537143A5 (ja)
CA2378148A1 (en) Nematicidal trifluorobutenes
CA2520541A1 (en) Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field
JP2005538696A5 (ja)
JP2008528624A5 (ja)
JP2009505964A5 (ja)
JP2003524387A5 (ja)
JP2001512666A5 (ja)
JP2003525623A5 (ja)
JP2004501211A5 (ja)
WO2003101394A3 (en) Defensins: use as antiviral agents
CA2426765A1 (en) Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis